6+ mon, 4+ day ago   (767+ words) News-Medical Be the first to rate this article Cytotrait secures £3 M seed funding to address global food security and sustainable agriculture Cytotrait, a biotechnology spinout company from The University of Manchester focussed on the development of novel traits for food…...

7+ mon, 2+ week ago   (691+ words) News-Medical Insilico Medicine and Qilu Pharmaceutical partner to develop AI-designed cardiometabolic drugs Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its subsidiary Shanghai…...

7+ mon, 2+ week ago   (304+ words) Vortex Biotech Holdings Limited has announced the opening of its advanced laboratory facilities at Manchester Science Park. The new site significantly enhances the company's R&D and commercial delivery capacity and strengthens its position as a leader in liquid biopsy…...

8+ mon, 4+ week ago   (812+ words) Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has entered a partnership with Cherry Biotech, a French company specializing in organ-on-chip and organoid technologies for biomedical research. Atelerix enters…...

9+ mon, 1+ week ago   (97+ words) Dr Nicola Thompson, CEO, TRIMTECH Therapeutics Ms Alison Lawton, Chair of the Board of Directors, TRIMTECH Therapeutics, commented: “TRIMTECH has built a strong scientific and organisational foundation to deliver on its mission. I look forward to leading the Board as…...

10+ mon, 4+ week ago   (180+ words) Keensight Capital (“Keensight”), one of the leading private equity managers dedicated to pan-European Growth Buyou investments, today announced it has acquired a majority stake in Bedfont® Scientific Ltd. (“Bedfont”), which designs and manufactures non-invasive breath analysis medical devices. Bedfont’s products…...

11+ mon, 5+ day ago   (388+ words) Aptamer Group plc, the developer of next-generation synthetic binders for the life sciences industry, has announced a significant development contract with a top 3 global pharmaceutical company to engineer Optimer® binders as targeted radiopharmaceuticals for potential therapeutic applications. Aptamer expands into…...

11+ mon, 2+ week ago   (753+ words) Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has entered into a new distribution agreement with CliniSciences, a leading European player in the distribution and development of solutions for…...

11+ mon, 3+ week ago   (227+ words) Enhanced Genomics ('Enhanced'), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced it has completed a financing round, extending its total Series A funding to $19 million. Investors in this latest funding…...